Biocompatible Polymer Colloids for Bionanotechnology Applications
Lead Research Organisation:
University of Sheffield
Department Name: Chemistry
Abstract
The three principal scientists in this research programme have highly complementary expertise. Prof. Armes is a synthetic polymer chemist, which means that he designs and makes long-chain molecules. Prof. Ryan is a polymeric materials scientist; his interests lie in the structure and properties of polymers, particularly on the nanometre length scale. Prof. Battaglia is a bio-engineer, who uses his quantitative background to bring academic rigour to the biological sciences. In the last few years, we have worked together (often as pairs, sometimes as a group of three) to conduct numerous inter-disciplinary scientific studies at Sheffield University. This collaborative approach allows us to tackle important scientific problems and questions that we could not contemplate addressing as individual investigators. This Platform Grant will provide us with the opportunity to formalise this ethos and to build a world-class close-knit team over the medium term. Our vision is to conduct transformative research in the area of polymer-based bionanotechnology, which we define as the application of synthetic polymers (man-made long-chain molecules) to solve important biological problems.
This proposal is underpinned by an important breakthrough in the design of bespoke organic nanoparticles recently made by Prof. Armes. His team has developed a robust, patented formulation that enables the efficient synthesis of biocompatible nanoparticles possessing spherical, worm-like or vesicular (i.e. hollow particles) morphologies directly in water using readily available starting materials. We are currently learning the design rules to reliably predict the final particle morphology, which is transforming our understanding compared to the previous ad hoc syntheses described in the literature. This new insight will provide us with an unprecedented opportunity to explore various biomedical applications, including enhanced live cell imaging, thermo-responsive gels for cell culture studies and the efficient delivery of antibodies into cells. Our work will involve the integration of innovative polymer chemistry, state-of-the-art characterisation techniques and world-class bio-engineering to produce a paradigm shift in the fast-moving inter-disciplinary field of bionanotechnology.
We intend to interact fruitfully with an informal network of six named internationally-renowned scientists to access their expertise and instrumentation and hence extract maximum scientific value from this Platform grant. Our post-doctoral scientists will be offered the opportunity to spend up to three months on secondment with our collaborators learning new techniques, experiencing other scientific cultures and enhancing their skill sets. Finally, in addition to our ambitious scientific programme, we intend to provide inspirational leadership and active mentoring for our excellent post-doctoral scientists to enable them to attain their long-term career goals.
All three principal scientists have worked extensively with industrial companies, ranging from the world's largest chemical company (BASF) to a single employee SME. Current sponsors include: P & G, Cytec, Biocompatibles, Reckitt Benckiser, Unilever, AkzoNobel, Croda, Scott Bader, SSL and Vivacta. Thus each Investigator is 'outward-facing' regarding the potential commercial impact of our work and is well aware of the value of IP protection (all are named inventors on multiple patent applications). Thus our team is both well-placed and has the appropriate contacts with various named companies (see case for support) to ensure that any new intellectual property resulting from this project will be fully exploited. Moreover, we have also been active in various outreach activities to communicate our findings to the general public. This is essential to assure the UK tax-payer of the importance of maintaining a long-term strategic investment in scientific research conducted in UK Universities.
This proposal is underpinned by an important breakthrough in the design of bespoke organic nanoparticles recently made by Prof. Armes. His team has developed a robust, patented formulation that enables the efficient synthesis of biocompatible nanoparticles possessing spherical, worm-like or vesicular (i.e. hollow particles) morphologies directly in water using readily available starting materials. We are currently learning the design rules to reliably predict the final particle morphology, which is transforming our understanding compared to the previous ad hoc syntheses described in the literature. This new insight will provide us with an unprecedented opportunity to explore various biomedical applications, including enhanced live cell imaging, thermo-responsive gels for cell culture studies and the efficient delivery of antibodies into cells. Our work will involve the integration of innovative polymer chemistry, state-of-the-art characterisation techniques and world-class bio-engineering to produce a paradigm shift in the fast-moving inter-disciplinary field of bionanotechnology.
We intend to interact fruitfully with an informal network of six named internationally-renowned scientists to access their expertise and instrumentation and hence extract maximum scientific value from this Platform grant. Our post-doctoral scientists will be offered the opportunity to spend up to three months on secondment with our collaborators learning new techniques, experiencing other scientific cultures and enhancing their skill sets. Finally, in addition to our ambitious scientific programme, we intend to provide inspirational leadership and active mentoring for our excellent post-doctoral scientists to enable them to attain their long-term career goals.
All three principal scientists have worked extensively with industrial companies, ranging from the world's largest chemical company (BASF) to a single employee SME. Current sponsors include: P & G, Cytec, Biocompatibles, Reckitt Benckiser, Unilever, AkzoNobel, Croda, Scott Bader, SSL and Vivacta. Thus each Investigator is 'outward-facing' regarding the potential commercial impact of our work and is well aware of the value of IP protection (all are named inventors on multiple patent applications). Thus our team is both well-placed and has the appropriate contacts with various named companies (see case for support) to ensure that any new intellectual property resulting from this project will be fully exploited. Moreover, we have also been active in various outreach activities to communicate our findings to the general public. This is essential to assure the UK tax-payer of the importance of maintaining a long-term strategic investment in scientific research conducted in UK Universities.
Planned Impact
All three principal scientists have worked extensively with industrial companies, ranging from the world's largest chemical company (BASF) to a single employee SME. Current sponsors include: P & G, Cytec, Biocompatibles, Reckitt Benckiser, Unilever, AkzoNobel, Croda, Scott Bader, SSL and Vivacta. Thus each Investigator is 'outward-facing' regarding the potential commercial impact of his work and is well aware of the value of IP protection.
Since 1997 Prof. Armes has received continuous funding from Biocompatibles to work on its proprietary monomer, 2-(methacryloyloxy)ethyl phosphorylcholine (MPC). This fruitful strategic collaboration has led to four maintained patents held by Biocompatibles and more than 45 publications with Biocompatibles employees as co-authors. Prof. Battaglia has also enjoyed a close relationship with Biocompatibles since he became an academic in 2006. Indeed, until his recent promotion to a personal Chair, he was the Biocompatibles' Lecturer in Bionanotechnology at U. Sheffield. He has filed four joint patent applications with Biocompatibles, primarily concerning the use of MPC-based copolymer vesicles for the intracellular delivery of bio-active materials (e.g. dyes, DNA etc.). In addition, he has been working with Abcam (a U. Cambridge spin-out with more than 200 employees) to evaluate these vesicles for the intracellular delivery of their commercial antibodies. Hence both Biocompatibles and Abcam are likely to be future beneficiaries of our research programme, once we have utilised the Platform grant to establish a strong independent IP position.
Another potential beneficiary is Polysciences, which has expressed strong interest in adding a Nile Blue vinyl monomer recently prepared in the Armes group to their catalogue range. Prof Armes visited Polysciences in March 2011 and has agreed to send a sample of this compound to this USA-based company in order to test the market. Its emission in the far red region of the visible spectrum is expected to be beneficial for in vitro studies of cells and other biological tissues using either confocal or fluorescence microscopy. We envisage that a second vinyl monomer based on a Cresyl Violet dye may be even more attractive in this regard, particularly as it appears to be a new chemical entity. Once we have optimised the synthesis of this compound, we plan to file a provisional patent application to protect this IP before discussing its commercial potential with third parties. If catalogue sales of such fluorescent labels are successful, this could create a new revenue stream for both Polysciences and the University of Sheffield. If required, toll manufacture of these compounds for Polysciences could be undertaken by Farapack Polymers, a U. Sheffield spin-out company that specialises in monomer/polymer synthesis and related services. This could lead to job creation within the UK.
Since 1995 Prof. Armes has maintained a good relationship with Cognis (Hythe, UK), which manufactures the methacrylic monomers such as glycerol monomethacrylate and 2-hydroxypropyl methacrylate that underpin this Platform grant. Cognis has previously funded a CASE PhD project with Prof. Armes and hosted his visit/lecture in Jan 2009. We will keep this company fully informed of our advances in synthetic polymer chemistry, since this could open up new commercial applications for our copolymers and may also lead to future inward investment by Cognis.
In 2005 U. Sheffield sold its IP rights to Fusion IP in a ten-year pipeline deal. This AIM-listed company has first refusal to commercialise inventions disclosed by University employees. Prof. Armes is currently negotiating with Fusion IP over the formation of a spin-out company to exploit his PCT patent application on RAFT aqueous dispersion polymerisation, which underpins this Platform Grant. Part of the business case for this commercial proposition is based on the potential broad impact of our technology on the life sciences.
Since 1997 Prof. Armes has received continuous funding from Biocompatibles to work on its proprietary monomer, 2-(methacryloyloxy)ethyl phosphorylcholine (MPC). This fruitful strategic collaboration has led to four maintained patents held by Biocompatibles and more than 45 publications with Biocompatibles employees as co-authors. Prof. Battaglia has also enjoyed a close relationship with Biocompatibles since he became an academic in 2006. Indeed, until his recent promotion to a personal Chair, he was the Biocompatibles' Lecturer in Bionanotechnology at U. Sheffield. He has filed four joint patent applications with Biocompatibles, primarily concerning the use of MPC-based copolymer vesicles for the intracellular delivery of bio-active materials (e.g. dyes, DNA etc.). In addition, he has been working with Abcam (a U. Cambridge spin-out with more than 200 employees) to evaluate these vesicles for the intracellular delivery of their commercial antibodies. Hence both Biocompatibles and Abcam are likely to be future beneficiaries of our research programme, once we have utilised the Platform grant to establish a strong independent IP position.
Another potential beneficiary is Polysciences, which has expressed strong interest in adding a Nile Blue vinyl monomer recently prepared in the Armes group to their catalogue range. Prof Armes visited Polysciences in March 2011 and has agreed to send a sample of this compound to this USA-based company in order to test the market. Its emission in the far red region of the visible spectrum is expected to be beneficial for in vitro studies of cells and other biological tissues using either confocal or fluorescence microscopy. We envisage that a second vinyl monomer based on a Cresyl Violet dye may be even more attractive in this regard, particularly as it appears to be a new chemical entity. Once we have optimised the synthesis of this compound, we plan to file a provisional patent application to protect this IP before discussing its commercial potential with third parties. If catalogue sales of such fluorescent labels are successful, this could create a new revenue stream for both Polysciences and the University of Sheffield. If required, toll manufacture of these compounds for Polysciences could be undertaken by Farapack Polymers, a U. Sheffield spin-out company that specialises in monomer/polymer synthesis and related services. This could lead to job creation within the UK.
Since 1995 Prof. Armes has maintained a good relationship with Cognis (Hythe, UK), which manufactures the methacrylic monomers such as glycerol monomethacrylate and 2-hydroxypropyl methacrylate that underpin this Platform grant. Cognis has previously funded a CASE PhD project with Prof. Armes and hosted his visit/lecture in Jan 2009. We will keep this company fully informed of our advances in synthetic polymer chemistry, since this could open up new commercial applications for our copolymers and may also lead to future inward investment by Cognis.
In 2005 U. Sheffield sold its IP rights to Fusion IP in a ten-year pipeline deal. This AIM-listed company has first refusal to commercialise inventions disclosed by University employees. Prof. Armes is currently negotiating with Fusion IP over the formation of a spin-out company to exploit his PCT patent application on RAFT aqueous dispersion polymerisation, which underpins this Platform Grant. Part of the business case for this commercial proposition is based on the potential broad impact of our technology on the life sciences.
Organisations
Publications
Frank V
(2016)
Frequent mechanical stress suppresses proliferation of mesenchymal stem cells from human bone marrow without loss of multipotency.
in Scientific reports
Ning Y
(2016)
Incorporating Diblock Copolymer Nanoparticles into Calcite Crystals: Do Anionic Carboxylate Groups Alone Ensure Efficient Occlusion?
in ACS macro letters
Ning Y
(2016)
Occlusion of Sulfate-Based Diblock Copolymer Nanoparticles within Calcite: Effect of Varying the Surface Density of Anionic Stabilizer Chains.
in Journal of the American Chemical Society
Mykhaylyk O
(2016)
Applications of shear-induced polarized light imaging (SIPLI) technique for mechano-optical rheology of polymers and soft matter materials
in Journal of Polymer Science Part B: Polymer Physics
Williams M
(2016)
Bespoke cationic nano-objects via RAFT aqueous dispersion polymerisation
in Polymer Chemistry
Jones E
(2016)
Addition of water to an alcoholic RAFT PISA formulation leads to faster kinetics but limits the evolution of copolymer morphology
in Polymer Chemistry
Mitchell D
(2016)
Combining Biomimetic Block Copolymer Worms with an Ice-Inhibiting Polymer for the Solvent-Free Cryopreservation of Red Blood Cells
in Angewandte Chemie
Penfold N
(2016)
pH-Responsive non-ionic diblock copolymers: protonation of a morpholine end-group induces an order-order transition
in Polymer Chemistry
Description | We have published a wide range of high-quality papers that demonstrate the versatility of PISA. |
Exploitation Route | Not sure at the present time |
Sectors | Chemicals Education Healthcare Pharmaceuticals and Medical Biotechnology |
Description | We have used this grant to become world-leading in the area of polymerisation-induced self-assembly (PISA), which is a powerful and versatile technique for the rational design of organic nanoparticles of controllable size, shape and surface chemistry. |
First Year Of Impact | 2012 |
Sector | Chemicals,Education,Healthcare,Pharmaceuticals and Medical Biotechnology |
Impact Types | Economic |
Title | Supporting Data for "Ionic and Nonspherical Polymer Nanoparticles in Nonpolar Solvents" (Macromolecules, doi: 10.1021/acs.macromol.0c00121) |
Description | All data are named with the monomer composition of the block copolymer (SMA, BzMA, or MOTMA) and the type of data (SAXS, DLS, or TEM). Small-angle X-ray scattering (SAXS) reciprocal space scattering data [Q in 1/Å, I(Q) in arb. unit, uncertainty I(Q)] Dynamic-light scattering (DLS) intensity-weighted size distributions [Bin location in nm, Proportion in %] Transmission electron microscopy (TEM) micrographs [Scale bars are all 200 nm] |
Type Of Material | Database/Collection of data |
Year Produced | 2020 |
Provided To Others? | Yes |
URL | https://zenodo.org/record/3746966 |
Title | Supporting Data for "Ionic and Nonspherical Polymer Nanoparticles in Nonpolar Solvents" (Macromolecules, doi: 10.1021/acs.macromol.0c00121) |
Description | All data are named with the monomer composition of the block copolymer (SMA, BzMA, or MOTMA) and the type of data (SAXS, DLS, or TEM). Small-angle X-ray scattering (SAXS) reciprocal space scattering data [Q in 1/Å, I(Q) in arb. unit, uncertainty I(Q)] Dynamic-light scattering (DLS) intensity-weighted size distributions [Bin location in nm, Proportion in %] Transmission electron microscopy (TEM) micrographs [Scale bars are all 200 nm] |
Type Of Material | Database/Collection of data |
Year Produced | 2020 |
Provided To Others? | Yes |
URL | https://zenodo.org/record/3746967 |
Title | Supporting data for "Influence of an ionic comonomer on polymerization-induced self-assembly of diblock copolymers in non-polar media" (Polymer Chemistry, 2020, doi:10.1039/D0PY00101E) |
Description | SAXS data [Q / (1/Å), I(Q) / Arb. unit, Uncertainty I(Q) / Arb. unit] provided as *.txt files DLS histograms [Diameter / nm, Proportion / %] provided as *.csv files |
Type Of Material | Database/Collection of data |
Year Produced | 2020 |
Provided To Others? | Yes |
URL | https://zenodo.org/record/3697000 |
Title | Supporting data for "Influence of an ionic comonomer on polymerization-induced self-assembly of diblock copolymers in non-polar media" (Polymer Chemistry, 2020, doi:10.1039/D0PY00101E) |
Description | SAXS data [Q / (1/Å), I(Q) / Arb. unit, Uncertainty I(Q) / Arb. unit] provided as *.txt files DLS histograms [Diameter / nm, Proportion / %] provided as *.csv files |
Type Of Material | Database/Collection of data |
Year Produced | 2020 |
Provided To Others? | Yes |
URL | https://zenodo.org/record/3697001 |